Andre Esteva is an American entrepreneur and AI scientist. He is CEO and Co-Founder of ArteraAI, a medical AI company that personalizes cancer therapy, is standard of care (NCCN Guidelines), reimbursed by Medicare, and deployed internationally. ArteraAI was named a TIME 2024 Best Invention and selected for the World Economic Forum's Global Innovators as one of the world's top growth-stage companies. Andre was named to the 2025 TIME100 Health list—TIME Magazine's recognition of the most influential people in health—and to Modern Healthcare's 40 Under 40 for 2025.
He has co-founded four companies with a combined market cap of $2.2B. Previously, he was Head of Medical AI at Salesforce Research, and held engineering roles at Google Research, Sandia National Labs, and GE Healthcare.
His research has been cited over 25,000 times. His publications have appeared on the covers of Nature and Nature Medicine—the first to show AI matching doctors at diagnosis. His work is featured in Cell, The Lancet, NeurIPS, TIME, and widely covered by the WSJ, Fortune, BBC, The Economist, and hundreds of outlets.
He earned his PhD in Computer Vision at Stanford, and graduated with highest honors in Electrical Engineering and Pure Math from UT-Austin, where he was Engineering Valedictorian.